InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

Re: Tekterra post# 2929

Tuesday, 03/14/2017 5:36:43 PM

Tuesday, March 14, 2017 5:36:43 PM

Post# of 3833
Good point. Unless they get a great offer they may just try and do a partnership for the skin conditions to continue the studies and wait for the CX readout.

If the CX readout is poor they can just support their partner and also try for a partnership on I-O. Not as big as a score, but maybe the Melanoma and AD are worth $8 and then I-O another $5-10.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News